Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndrome

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1988-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.32.9.1300PMID 3058016PMCID PMC175855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection

  2005cited by this paper
• Reverse Transcriptase Activity (RTA) in Lymphocyte Cultures of AIDS Patients Treated with HPA-23

  1986cited by this paper
• Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome.

  1985cited by this paper
• Inhibition of RNA-dependent DNA polymerases of AIDS and SAIDS retroviruses by HPA-23 (ammonium-21-tungsto-9-antimoniate)

  1985cited by this paper
• Inhibition of DNA polymerase alpha activity by ammonium 21-tungsto-9-antimoniate (HPA23).

  1984cited by this paper
• Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

  1984cited by this paper
• Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

  1984cited by this paper
• Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

  1984cited by this paper
• Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine.

  1984cited by this paper
• Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

  1983cited by this paper
• Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases.

  1983cited by this paper
• Effects of 5-tungsto-2-antimoniate in oncogenic DNA and RNA virus-cell systems.

  1977cited by this paper
• Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate.

  1975cited by this paper
• Detection , Isolation , and Continuous Production of Cytopathic Retroviruses ( HTLV-III ) from Patients with AIDS and Pre-AIDS

  year unknowncited by this paper

• Low-grade systemic inflammation links heavy metal exposures to mortality: A multi-metal inflammatory index approach.

  2024cites this paper
• Polyoxometalates based nanocomposites for bioapplications

  2023cites this paper
• Self-assembly morphology and solid state of four organic-polyoxometalate hybrids based on berberine

  2023cites this paper
• Polyoxometalate Nanoparticles as a Potential Glioblastoma Therapeutic via Lipid-Mediated Cell Death

  2022cites this paper
• Functionalized polyoxometalate microspheres ensure selective adsorption of phosphoproteins and glycoproteins.

  2021cites this paper
• “How Many Dead Hemophiliacs Do You Need?” And the Band Played on (1993)

  2020cites this paper
• Effective inhibitory activity against MCF-7, A549 and HepG2 cancer cells by a phosphomolybdate based hybrid solid.

  2020cites this paper
• Polyoxometalate-Based Nanomaterials Toward Efficient Cancer Diagnosis and Therapy.

  2020cites this paper
• Interactions between polyoxometalates and biological systems: from drug design to artificial enzymes.

  2019cites this paper
• Polyoxometalates as Potential Next‐Generation Metallodrugs in the Combat Against Cancer

  2018cites this paper
• Im Kampf gegen Krebs: Polyoxometallate als nächste Generation metallhaltiger Medikamente

  2018cites this paper
• Nanocomposites of Polyoxometalates and Chitosan-Based Polymers as Tuneable Anticancer Agents

  2018cites this paper
• Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate

  2018cites this paper
• Decavanadate Inhibits Mycobacterial Growth More Potently Than Other Oxovanadates

  2018cites this paper
• Synthesis and evaluation of pyridinium polyoxometalates as anti-HIV-1 agents.

  2017cites this paper
• Target Delivery of a Novel Antitumor Organoplatinum(IV)‐Substituted Polyoxometalate Complex for Safer and More Effective Colorectal Cancer Therapy In Vivo

  2016cites this paper
• ctDNA interaction of Co-containing Keggin polyoxomolybdate and in vitro antitumor activity of free and its nano-encapsulated derivatives

  2016cites this paper
• Synthesis, structure, self-assembly and genotoxicity evaluation of a series of Mn-Anderson cluster based polyoxometalate–organic hybrids

  2015cites this paper
• In vitro antitumor activity of free and nano-encapsulated Na5[PMo10V2O40]·nH2O and its binding properties with ctDNA by using combined spectroscopic methods.

  2015cites this paper
• In Vitro Antitumor Activity of a Keggin Vanadium-Substituted Polyoxomolybdate and Its ctDNA Binding Properties

  2015cites this paper
• In vitro antitumor activity of parent and nano-encapsulated mono cobalt-substituted Keggin polyoxotungstate and its ctDNA binding properties.

  2014cites this paper
• Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets

  2014cites this paper
• Synthesis, Crystal Structure and Antitumor Activities of a New Cobalt-containing Tungstoantimonate Na9[{Na(H2O)2}3{Co(H2O)}3 (α-B-SbW9O33)2]·28H2O

  2014cites this paper
• Metal-based antimicrobial protease inhibitors.

  2013cites this paper
• Trimethyl and carboxymethyl chitosan carriers for bio-active polymer-inorganic nanocomposites.

  2013cites this paper
• Polyoxometalates Active Against Tumors, Viruses, and Bacteria

  2013cites this paper
• Spectroscopic and electrochemical study of the interconversion and decomplexation of cobalt(II) sandwich polyoxometalates based on a Dawson-type anion.

  2012cites this paper
• pH-Controlled syntheses of two hybrids based on octamolybdate and enrofloxacin

  2012cites this paper
• Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy

  2012cites this paper
• Study on ligation of copper complexes of the quinolone antibacterial drugs and octamolybdates POMs

  2012cites this paper
• Identification of a polyoxometalate inhibitor of the DNA binding activity of Sox2.

  2011cites this paper
• Ligation of the quinolone antibacterial agent pipemidic acid to Keggin polyoxotungstates

  2011cites this paper
• Synthesis, characterisation and cytotoxicity of polyoxometalate/carboxymethyl chitosan nanocomposites.

  2011cites this paper
• Targeted delivery of polyoxometalate nanocomposites.

  2011cites this paper
• Study of the first antibacterial agent pipemidic acid modifying Keggin polyoxometalate

  2011cites this paper
• The introduction of antibacterial drug pipemidic acid into the POM field: Syntheses, characterization and antitumor activity

  2011cites this paper
• Molecular simulation study of the binding mechanism of [α-PTi2W10O40]7− for its promising broad-spectrum inhibitory activity to FluV-A neuraminidase

  2010cites this paper
• Does speciation matter for tungsten ecotoxicology?

  2010cites this paper
• Does speciation matter for tungsten ecotoxicology?

  2010cites this paper
• HIV-1 protease inhibition potential of functionalized polyoxometalates

  2010cites this paper
• Synthesis and In vitro Anti-HIV-1 Activity of Electrochemically Reduced Praseodymium Salts of 12-tungstophosphate Acid

  2006cites this paper
• Anti-tumor, -viral, and -bacterial activities of polyoxometalates for realizing an inorganic drug

  2005cites this paper
• Cytotoxic effects of novel polyoxotungstates and a platinum compound on human cancer cell lines

  2005cites this paper
• Polyoxotungstates reduce the beta-lactam resistance of methicillin-resistant Staphylococcus aureus.

  2005cites this paper
• New liposome-encapsulated-polyoxometalates: synthesis and antitumoral activity.

  2005cites this paper
• Synthesis, characterization and antiviral activity against influenza virus of a series of novel manganese-substituted rare earth borotungstates heteropolyoxometalates.

  2004cites this paper
• 4.11 – Polyoxometalates: Reactivity

  2003cites this paper
• Polyoxometalate HIV-1 protease inhibitors. A new mode of protease inhibition.

  2001cites this paper
• Antiviral Activity of Mixed-Valence Rare Earth Borotungstate Heteropoly Blues against Influenza Virus in Mice

  2000cites this paper
• Medicinal Inorganic Chemistry

  1999cites this paper
• Polyoxometalates and Fullerenes as Anti-HIV Agents

  1999cites this paper
• Polyoxoanions are cytotoxic to malignant glioma cells

  1998cites this paper
• Polyoxometalates in Medicine.

  1998cites this paper
• Synergistic effect of polyoxotungstates in combination with beta-lactam antibiotics on antibacterial activity against methicillin-resistant Staphylococcus aureus.

  1996cites this paper
• Novel Transition Metal Heteropolymetalates and Derivatives: Structural Chemistry, Biological and Catalytic Relevance

  1995cites this paper
• Structure-activity correlationship and strain specificity of polyoxometalates in anti-human immunodeficiency virus activity.

  1995cites this paper
• Enzyme Interactions with Labile Oxovanadates and Other Polyoxometalates

  1994cites this paper
• Synthesis, characterization, and biological activity of a new potent class of anti-HIV agents, the peroxoniobium-substituted heteropolytungstates.

  1994cites this paper
• Of Therapy, Toxicity and Tungstates: The Anti-Retroviral Pharmacology of Polyoxometalates

  1994cites this paper
• Polyoxometalates in AIDS Therapy

  1994cites this paper
• Pharmacokinetics of antiviral polyoxometalates in rats

  1994cites this paper
• In vitro antiviral activity of polyoxomolybdates. Mechanism of inhibitory effect of PM-104 (NH4)12H2(Eu4(MoO4)(H2O)16(Mo7O24)4).13H2O on human immunodeficiency virus type 1.

  1993cites this paper
• Polyoxometalates in catalytic selective homogeneous oxygenation and anti-HIV chemotherapy

  1993cites this paper
• Polyoxometalates for molecular devices: Antitumor activity and luminescence

  1993cites this paper
• Synthesis, characterization, and anti-human immunodeficiency virus activity of water-soluble salts of polyoxotungstate anions with covalently attached organic groups.

  1992cites this paper
• Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase.

  1992cites this paper
• Insights Into HIV Chemotherapy*

  1992cites this paper
• Antiviral therapy of HIV infection.

  1991cites this paper
• Inhibition of proliferation of human immunodeficiency virus type 1 by novel heteropolyoxotungstates in vitro.

  1991cites this paper
• Anti‐HIV‐1, Cytotoxic, and Biological Properties of Selected Polyoxometalate Compounds a

  1990cites this paper
• Biology of retroviruses. Detection, molecular biology, and treatment of retroviral infection.

  1990cites this paper
• Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates.

  1990cites this paper
• Detection, prevention, and treatment of retroviral infections.

  1990cites this paper
• Therapy for human immunodeficiency virus infection-1989.

  1990cites this paper
• Biology of retroviruses: detection, molecular biology, and treatment of retroviral infection.

  1990cites this paper
• Antiviral chemotherapy for infection with human immunodeficiency virus.

  1989cites this paper
• Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.

  1989cites this paper
• Antiviral Therapy in Human Immunodeficiency Virus Infection

  1989cites this paper